Product information and disease descriptionProduct descriptionProduct information
Access and distribution
7 evidence topics · 5 sources
Commercial launch readiness: sales force, medical affairs, and brand preparation, November 2026
Payer engagement before approval
Anticipated coverage at launch: commercial plans first, Medicare through the exception process
Patient support program
Target prescribers: about 60,000 physicians, 60% primary care and 40% specialty
Manufacturing by third-party contract manufacturers
Specialty pharmacy or limited distribution network
No evidence found.